Novel approach to quantitative polymerase chain reaction using real- time detection: Application to the detection of gene amplification in breast cancer

International Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 661-666

  Bièche, Ivan ^a,b   Olivi, Martine ^a   Champème, Marie Hélène ^b   Vidaud, Dominique ^a   Lidereau, Rosette ^b   Vidaud, Michel ^a,c  

^a Laboratoire des Sciences Vegetales   (France)

^b CENTRE RENÉ HUGUENIN   (France)

^c UER des Sciences Pharmaceutiques et Biologiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE DOSAGE; HUMANS; POLYMERASE CHAIN REACTION;

EID: 0031790955     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.0.CO;2-I     Document Type: Article

References (21)

1. AN, H.X., NIEDERACHER, D., BECKMANN, M.W., GÖHRING, U.J., SCHARL, A., PICARD, F., VAN ROEYEN, C., SCHNÜRCH, H.G. and BENDER, H.G., erbB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int. J. Cancer (Pred. Oncol.), 64, 291-297 (1995).
2. BERNS, E.M.J.J., KLUN, J.G.M., VAN PUTTEN, W.L.J., VAN STAVEREN, I.L., PORTENGEN, H. and FOEKENS. J.A., c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res., 52, 1107-1113 (1992).
3. BIÈCHE, I. and LIDEREAU, R., Genetic alterations in breast cancer. Genes Chrom. Cancer, 14, 227-251 (1995).
4. BORG, A., BALDETORP, B., FERNO, M., OLSSON, H. and SIGURDSSON, H., c-myc amplification is an independent prognostic factor in post-menopausal breast cancer. Int. J. Cancer, 51, 687-691 (1992).
5. CELL F.S., COHEN, M.M., ANTONARAKJS, S.E., WERTHEIMER, E., ROTH, J. and SHULDINER, A.R., Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences. Genomics, 21, 304-310 (1994).
6. COURJAL, F., CUNY, M., SIMONY-LAFONTAINE, J., LOUASSON, G., SPEISER, P., ZEILLINGER, R., RODRIGUEZ, C. and THEILLET, C., Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res., 57, 4360-4367 (1997).
7. DENG, G., YU, M., CHEN, L.C., MOORE, D., KURISU, W., KALLIONIEMI, A., WALDMAN, F.M., COLLINS, C. and SMITH, H.S., Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction. Breast Cancer Res. Treat., 40, 271-281 (1996).
8. GELMINL S., ORIANDO, C., SESTINL R., VONA, G., PINZANL P., RUOCCO, L. and PAZZAGLI, M., Quantitative polymerase chain reaction-based homogeneous assay with fluorosenic probes to measure c-erB-2 oncogene amplification. Clin. Chem., 43, 752-758 (1997).
9. GIBSON, U.E.M., HEID, C.A. and WILLIAMS, P.M., A novel method for real-time quantitative RT-PCR. Genome Res., 6, 995-1001 (1996).
10. HEID, C.A., STEVENS, J., LIVAK, K.J. and WILLIAMS, P.M., Real-time quantitative PCR. Genome Res., 6, 986-994 (1996).
11. HOLLAND, P.M., ABRAMSON, R.D., WATSON, R. and GELFAND, D.H., Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermits aqitaticus DNA polymerase. Proc. nat. Acad. Sci. (Wash.), 88, 7276-7280 (1991).
12. KALLIONIEMI, A., KALLIONIEMI, O.P., PIPER, J., TANNER, M., STOKKES, T., CHEN, L., SMITH, H.S., PINKEL, D., GRAY, J.W. and WALDMAN, P.M., Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. nat. Acad. Sci. (Wash.), 91, 2156-2160 (1994).
13. LEE, L.G., CONNELL, C.R. and BIOCH, W., Allelic discrimination by nick-translation PCR with fluorogenic probe. Nucleic Acids Res., 21, 3761-3766 (1993).
14. LONGO, N., BERNINGER, N.S. and HARTLEY, J.L., Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene, 93, 125-128 (1990).
15. MUSS, H.B., THOR, A.D., BERRY, D.A., KUTE, T., LIU, E.T., KOERNER, F., CIRRINCIONE, C.T., BUDMAN, D.R., WOOD, W.C., BARCOS, M. and HENDERSON, I.C., c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. New Engl. J. Med., 330, 1260-1266 (1994).
16. PAULETTI, G., GODOLPHIN, W., PRESS, M.F. and SALMON, D.J., Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene, 13, 63-72 (1996).
17. PIATAK, M., LUK, K.C., WILLIAMS, B. and LIFSON, J.D., Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques, 14, 70-80 (1993).
18. SCHUURING, E., VERHOEVEN, E., VAN TINTEREN, H., PETERSE, J.L., NUNNIK, B., THUNNISSEN, F.B.J.M., DEVILEE, P., CORNELISSE, C.J., VAN DE VIJVER, M.J., MOOI, W.J. and MICHALIDES, R.J.A.M., Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52, 5229-5234 (1992).
19. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN, W.S., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182 (1987).
20. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
21. VALERON, P.P., CHIRINO, R., FERNANDEZ, L., TORRES, S., NAVARRO, D., AGUIAR. J., CABRERA, J.J., DIAZ-CHICO, B.N. and DIAZ-CHICO, J.C., Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer. Int. J. Cancer, 65, 129-133 (1996).